Efficacy parameters were assessed
using visual grading of facial and periocular skin while
changes in viscoelasticity properties were assessed by
cutometery. Cutaneous tolerability was evaluated both
clinically and subjectively using a four-point scale and by
monitoring adverse event reports. As this was an
exploratory analysis, no primary efficacy parameter was
pre-identified.